Presence of calreticulin mutations in JAK2-negative polycythemia vera

Klampfl, 2013, Somatic mutations of calreticulin in myeloproliferative neoplasms., N Engl J Med, 369, 2379, 10.1056/NEJMoa1311347 Nangalia, 2013, Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2., N Engl J Med, 369, 2391, 10.1056/NEJMoa1312542 Tefferi, Long-term survival and blast transformation in molecularly-annotated essential thrombocythemia, polycythemia vera and myelofibrosis [published online ahead of print July 18, 2014]., Blood Cross, 2011, Genetic and epigenetic complexity in myeloproliferative neoplasms., Hematology Am Soc Hematol Educ Program, 208 Broséus, 2014, Low rate of calreticulin mutations in refractory anaemia with ring sideroblasts and marked thrombocytosis., Leukemia, 28, 1374, 10.1038/leu.2014.49 Tefferi, 2014, CALR vs JAK2 vs MPL-mutated or triple-negative myelofibrosis: clinical, cytogenetic and molecular comparisons., Leukemia, 28, 1472, 10.1038/leu.2014.3 Lundberg, 2014, Clonal evolution and clinical correlates of somatic mutations in myeloproliferative neoplasms., Blood, 123, 2220, 10.1182/blood-2013-11-537167 McGaffin, 2014, JAK2 V617F and CALR mutations are not mutually exclusive; findings from retrospective analysis of a small patient cohort., Br J Haematol, 167, 276, 10.1111/bjh.12969 Lippert, 2006, The JAK2-V617F mutation is frequently present at diagnosis in patients with essential thrombocythemia and polycythemia vera., Blood, 108, 1865, 10.1182/blood-2006-01-013540 Carillo, 2011, Nested high-resolution melting curve analysis a highly sensitive, reliable, and simple method for detection of JAK2 exon 12 mutations—clinical relevance in the monitoring of polycythemia., J Mol Diagn, 13, 263, 10.1016/j.jmoldx.2010.12.002 Boyd, 2010, Clinical utility of routine MPL exon 10 analysis in the diagnosis of essential thrombocythaemia and primary myelofibrosis., Br J Haematol, 149, 250, 10.1111/j.1365-2141.2010.08083.x Cassinat, 2014, Interferon alfa therapy in CALR-mutated essential thrombocythemia., N Engl J Med, 371, 188, 10.1056/NEJMc1401255 Cassinat, 2008, Classification of myeloproliferative disorders in the JAK2 era: is there a role for red cell mass?, Leukemia, 22, 452, 10.1038/sj.leu.2404908 Johansson, 2005, An elevated venous haemoglobin concentration cannot be used as a surrogate marker for absolute erythrocytosis: a study of patients with polycythaemia vera and apparent polycythaemia., Br J Haematol, 129, 701, 10.1111/j.1365-2141.2005.05517.x Alvarez-Larrán, 2012, Red cell mass measurement in patients with clinically suspected diagnosis of polycythemia vera or essential thrombocythemia., Haematologica, 97, 1704, 10.3324/haematol.2012.067348